Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Experimental Medicine|June 25, 2008
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsivenessGerald Willimsky, Melinda Czéh, Christoph Loddenkemper, et al.
Blood|July 14, 2018
Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in miceDana Hoser, Christian Schön, Christoph Loddenkemper, et al.
Cancer Research|March 22, 2018
ERAP1-Dependent Antigen Cross-Presentation Determines Efficacy of Adoptive T-cell Therapy in MiceKarin Schmidt, Christin Keller, Anja A Kühl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2010
In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL toleranceChristian Buschow, Jehad Charo, Kathleen Anders, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Fas expression by tumor stroma is required for cancer eradicationJoanna J Listopad, Thomas Kammertoens, Kathleen Anders, et al.
Elife|April 20, 2021
In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivoGerald Willimsky, Christin Beier, Lena Immisch, et al.
European Journal of Immunology|August 7, 2010
Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivoShabnam Shalapour, Katrin Deiser, Ozen Sercan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLsBernhard Frankenberger, Heike Pohla, Elfriede Noessner, et al.
Cancers|April 12, 2022
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine RepertoiresCorinna Grunert, Gerald Willimsky, Caroline Anna Peuker, et al.
Pageof 15